MOORHEAD, Minn. — Nearly two years after the Supreme Court overturned Roe v. Wade, dramatically changing the U.
S. landscape for abortion, abortion rights supporters Thursday saw a rare win from a separate high court decision. In a unanimous opinion, the Supreme Court tossed out a challenge from a coalition of anti-abortion doctors to the federal regulation of mifepristone — an abortion drug used in more than half of medication abortions.
The ruling maintains the status quo of how mifepristone can be prescribed, distributed and how far along into pregnancy it can be taken. But unlike with earlier Supreme Court wins, instead of celebrating abortion rights, supporters expressed temporary relief. “This ruling is a relief, FOR NOW.
This was simply a procedural decision stating the doctors did not have standing,” wrote Tammi Kromenaker, director of Red River Women’s Clinic in Moorhead, Minn., in an email shortly after the decision. “It in no way affirms that SCOTUS will maintain access to Mifepristone in the future if a new case is brought before them.
” “People need to celebrate this win and then get back to the work of staying vigilant and lifting up the attacks on abortion access,” said Kromenaker, whose clinic provides abortions one day a week, largely serving North Dakota, South Dakota and Minnesota. Kromenaker’s sentiments were echoed by advocacy groups, medical providers and federal lawmakers who back reproductive rights. “Let’s be clear — today’s .
